We are live on
!
Find out more
SLI
Sumitomo Life Insurance Portfolio holdings
AUM
$4.25B
1-Year Est. Return
23.69%
This Fund
S&P 500
This Quarter
Est. Return
+9.81%
1 Year Est. Return
+23.69%
3 Year Est. Return
+58.47%
5 Year Est. Return
+69.86%
10 Year Est. Return
+300.85%
AUM
$883M
AUM Growth
+$114M
(+15%)
Cap. Flow
+$43.9M
Cap. Flow
% of AUM
4.97%
Top 10 Holdings %
Top 10 Hldgs %
25.44%
Holding
268
New
3
Increased
245
Reduced
14
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$2.03M |
| 2 |
Microsoft
MSFT
|
+$1.77M |
| 3 |
Fidelity National Information Services
FIS
|
+$1.7M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$1.4M |
| 5 |
Bright Horizons
BFAM
|
+$1.32M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$2.36M |
| 2 |
Visteon
VC
|
+$1.15M |
| 3 |
Edwards Lifesciences
EW
|
+$1.01M |
| 4 |
Cintas
CTAS
|
+$894K |
| 5 |
Public Service Enterprise Group
PEG
|
+$709K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.99% |
| 2 | Financials | 14.65% |
| 3 | Healthcare | 13.41% |
| 4 | Consumer Discretionary | 9.8% |
| 5 | Communication Services | 9.35% |
Similar funds
CIC
AI
NCM
ATPW
DT
AC
IWM
CW
Sumitomo Life Insurance's Q4 2019 Portfolio in Review
As of Q4 2019, Sumitomo Life Insurance held 268 positions worth $883M, up 15% from $769M the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Sumitomo Life Insurance deployed $43.9M of net new capital in Q4 2019, opening 3 new positions and adding to 245 existing holdings. Its largest new stake was Bright Horizons: 8,818 shares worth $1.32M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Edwards Lifesciences, an estimated $1.01M trimmed.
- Sumitomo Life Insurance's largest Q4 2019 buy was Bright Horizons: 8,818 shares worth $1.32M.
- Sumitomo Life Insurance added most to Meta Platforms (Facebook) in Q4 2019, an estimated $2.03M increase.
- Sumitomo Life Insurance's biggest Q4 2019 reduction was Edwards Lifesciences, cutting an estimated $1.01M.
- Sumitomo Life Insurance fully exited Celgene Corp in Q4 2019, selling an estimated $2.36M.
- Sumitomo Life Insurance's ten largest holdings make up 25% of its $883M portfolio in Q4 2019.
- Sumitomo Life Insurance opened 3 new positions and closed 4 in Q4 2019.
- Sumitomo Life Insurance's portfolio value rose 15% quarter-over-quarter to $883M.
Based on Sumitomo Life Insurance's 13F filing for Q4 2019, filed 24 Jan 2020.